Therapeutic Targeting of PIM Protein Kinases in a Subset of T-Cell Acute Lymphoblastic Leukemia

被引：0

作者：

Padi, Sathish Kumar Reddy ^{[1
]}

Luevano, Libia A. ^{[1
]}

An, Ningfei ^{[2
]}

Pandey, Ritu ^{[3
]}

Singh, Neha ^{[1
]}

Song, Jin H. ^{[3
]}

Aster, Jon C. ^{[4
]}

Yu, Xue-Zhong ^{[5
]}

Mehrotra, Shikhar ^{[6
]}

Kraft, Andrew S. ^{[1
]}

机构：

[1] Univ Arizona, Ctr Canc, Tucson, AZ USA

[2] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA

[3] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA

[5] Med Univ S Carolina, Microbiol & Immunol, Charleston, SC USA

[6] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.2742.2742

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2742

引用

页数：4

共 50 条

[41] T-Cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia
Mantadakis, Elpis
Danilatou, Vassiliki
Stiakaki, Eftichia
Paterakis, George
Papadhimitriou, Stefanos
Kalmanti, Maria
PEDIATRIC BLOOD & CANCER, 2007, 48 (03) : 354 - 357
[42] T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma: One disease or two?
Raetz, EA
Perkins, SL
Bhojwani, D
Carroll, WL
Min, DJ
BLOOD, 2003, 102 (11) : 578A - 578A
[43] Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia
Bontoux, Christophe
Simonin, Mathieu
Garnier, Nathalie
Lhermitte, Ludovic
Touzart, Aurore
Andrieu, Guillaume
Bruneau, Julie
Lengline, Etienne
Plesa, Adriana
Boissel, Nicolas
Baruchel, Andre
Bertrand, Yves
Molina, Thierry Jo
Macintyre, Elizabeth
Asnafi, Vahid
MODERN PATHOLOGY, 2022, 35 (09) : 1227 - 1235
[44] GENOMIC ABNORMALITIES UNDERLYING HIGH PIM1 EXPRESSION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
La Starza, R.
Messina, M.
Gianfelici, V.
Pierini, V.
Matteucci, C.
Pierini, T.
Limongi, M. Z.
Arniani, S.
Moretti, M.
Vitale, A.
Chiaretti, S.
Foa, R.
Mecucci, C.
HAEMATOLOGICA, 2018, 103 : S57 - S58
[45] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
S Peirs
V Frismantas
F Matthijssens
W Van Loocke
T Pieters
N Vandamme
B Lintermans
M P Dobay
G Berx
B Poppe
S Goossens
B C Bornhauser
J-P Bourquin
P Van Vlierberghe
Leukemia, 2017, 31 : 2037 - 2047
[46] Therapeutic potential of mir-15b/16-2 targeting in T-cell acute lymphoblastic leukemia
Gonzalez Garcia, Sara
Garzon, Ramiro
Croce, Carlo M.
Toribio, Maria L.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 393 - 393
[47] Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
Peirs, S.
Frismantas, V.
Matthijssens, F.
Van Loocke, W.
Pieters, T.
Vandamme, N.
Lintermans, B.
Dobay, M. P.
Berx, G.
Poppe, B.
Goossens, S.
Bornhauser, B. C.
Bourquin, J-P
Van Vlierberghe, P.
LEUKEMIA, 2017, 31 (10) : 2037 - 2047
[48] Development of Proteolytic Targeting Chimeras to Target Lck in T-Cell Acute Lymphoblastic Leukemia
Hu, Jianzhong
Jarusiewicz, Jamie
Min, Jaeki
Yang, Lei
Chepyala, Divyabharathi
Actis, Marisa
Rowland, Lauren
Du, Guoqing
Smart, Brandon
Maxwell, Dylan
Xie, Boer
Yoshimura, Satoshi
Peng, Junmin
Teachey, David
Rankovic, Zoran
Yang, Jun J.
BLOOD, 2021, 138
[49] Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
Yana Pikman
Nicole Ocasio-Martinez
Gabriela Alexe
Boris Dimitrov
Samuel Kitara
Frances F. Diehl
Amanda L. Robichaud
Amy Saur Conway
Linda Ross
Angela Su
Frank Ling
Jun Qi
Giovanni Roti
Caroline A. Lewis
Alexandre Puissant
Matthew G. Vander Heiden
Kimberly Stegmaier
Leukemia, 2022, 36 : 348 - 360
[50] Targeting FOXM1 Transcription Factor In T-Cell Acute Lymphoblastic Leukemia
Tufekci, Ozlem
Yandim, Melis Kartal
Oren, Hale
Irken, Gulersu
Baran, Yusuf
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →